Cipla reported INR32.3B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Arca Biopharma USD 4.16M 1.95M Dec/2025
aTyr Pharma USD 2.76M 52.32M Mar/2026
Bio Path USD 5.16M 260K Mar/2026
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Capricor Therapeutics 3.93M 2.27M Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
Cipla INR 32.3B 1.95B Mar/2026
Dr.Reddys Laboratories INR 30.38B 10.42B Mar/2026
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sun Pharmaceuticals INR 73.34B 6.28B Mar/2026
TherapeuticsMD USD 143K 4K Jun/2024
UPL INR 120.18B 8.79B Mar/2026